Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex.
The affinities for the benzodiazepine binding site of the GABA(A) receptor of 21 flavonoids have been studied using [(3)H]flumazenil binding to rat cortical membranes in vitro. We show that flavonoids with high affinity for the benzodiazepine receptor in vitro spanning the whole efficacy range from agonists (1q) to inverse agonists (1l) can be synthesized. The receptor binding properties of the flavonoids studied can successfully be rationalized in terms of a comprehensive pharmacophore model recently developed by Cook and co-workers (Drug Des. Dev. 1995, 12, 193-248), supporting the validity of this model. However, in contrast to the requirement by the model that an interaction with the hydrogen bond-accepting site A2 is necessary for compounds to display inverse agonistic activity, 6-methyl-3'-nitroflavone (1l), which cannot engage in such an interaction, nevertheless displays inverse agonism. The analysis of the binding affinities of 3'- and 4'-substituted flavones in terms of the pharmacophore model has yielded new information for the further development of the pharmacophore model.
Dekermendjian
K
K
Research Institute of Biological Psychiatry, Sct. Hans Hospital, DK-4000 Roskilde, Denmark. kim.dekermendjian@shh.hosp.dk
Kahnberg
P
P
Witt
M R
MR
Sterner
O
O
Nielsen
M
M
Liljefors
T
T
D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism*; D005419:Flavonoids / Q000737:chemistry* / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008958:Models, Molecular; D008968:Molecular Conformation; D011869:Radioligand Assay; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000378:metabolism*; D015203:Reproducibility of Results; D013329:Structure-Activity Relationship
D005419:Flavonoids; D011963:Receptors, GABA-A